ProShares UltraShort Nasdaq Biotechnology

BIS · ETF

$11.46+$0.2504 (+2.23%)TodayMarket closed ·
Prev close $11.21

About BIS

BIS was created on 2010-04-07 by ProShares. The fund's investment portfolio concentrates primarily on health care equity. BIS provides -2x exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.

Issuer
ProShares
Tracks
NASDAQ / Biotechnology
Expense ratio
0.95%
Assets under management
$1.83M
Inception
Apr 7, 2010
Asset class
Equity

BIS key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
7.39K
Volume
14.25K
Open price
$11.44
High today
$11.56
Low today
$11.36
52 Week high
$23.61
52 Week low
$10.51

ProShares UltraShort Nasdaq Biotechnology (BIS) at a glance

As of Oct 23, 2026, ProShares UltraShort Nasdaq Biotechnology (BIS) shares are priced at $11.46, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $11.36 and $11.56. The current price is 0.9% above the day's low and 0.9% below its high.

Volume so far is 14.25K shares, above the average of 7.39K shares a day.

Over the past year ProShares UltraShort Nasdaq Biotechnology has ranged from $10.51 to $23.61, and now sits 7% of the way up that range.

BIS news

  • Press releaseBusiness Wire

    ProShares Announces ETF Share Splits

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.